Hostname: page-component-78c5997874-m6dg7 Total loading time: 0 Render date: 2024-11-19T23:53:38.735Z Has data issue: false hasContentIssue false

MAPPING OF HEALTH TECHNOLOGY ASSESSMENT IN SELECTED COUNTRIES

Published online by Cambridge University Press:  02 December 2013

Wija Oortwijn
Affiliation:
ECORYS Nederland BV
Pieter Broos
Affiliation:
ECORYS Nederland BV, Dutch Order of Medical Specialists
Hindrik Vondeling
Affiliation:
University of Southern Denmark, University of Twente
David Banta
Affiliation:
ECORYS Nederland BV
Lora Todorova
Affiliation:
Novo Nordisk International Operations A/S

Abstract

Objectives: The aim of this study was to develop and apply an instrument to map the level of health technology assessment (HTA) development at country level in selected countries. We examined middle-income countries (Argentina, Brazil, India, Indonesia, Malaysia, Mexico, and Russia) and countries well-known for their comprehensive HTA programs (Australia, Canada, and United Kingdom).

Methods: A review of relevant key documents regarding the HTA process was performed to develop the instrument which was then reviewed by selected HTAi members and revised. We identified and collected relevant information to map the level of HTA in the selected countries. This was supplemented by information from a structured survey among HTA experts in the selected countries (response rate: 65/385).

Results: Mapping of HTA in a country can be done by focusing on the level of institutionalization and the HTA process (identification, priority setting, assessment, appraisal, reporting, dissemination, and implementation in policy and practice). Although HTA is most advanced in industrialized countries, there is a growing community in middle-income countries that uses HTA. For example, Brazil is rapidly developing effective HTA programs. India and Russia are at the very beginning of introducing HTA. The other middle-income countries show intermediate levels of HTA development compared with the reference countries.

Conclusions: This study presents a set of indicators for documenting the current level and trends in HTA at country level. The findings can be used as a baseline measurement for future monitoring and evaluation. This will allow a variety of stakeholders to assess the development of HTA in their country, help inform strategies, and justify expenditure for HTA.

Type
Methods
Copyright
Copyright © Cambridge University Press 2013 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.Wilsdon, T, Serota, A. A comparative analysis of the role and impact of health technology assessment. London: Charles River Associates. 2011.Google Scholar
2.Børlum Kristensen, F, Palmhoj Nielsen, C, et al.“What is health technology assessment?” in health technology assessment and health policy-making in Europe. Geneva: World Health Organization on behalf of the European Observatory on Health Systems and Policies; 2008.Google Scholar
3.Busse, R, Orvain, J, Velasco, M, et al.Best practice in undertaking and reporting health technology assessments. Working group 4 report. Int J Technol Assess Health Care. 2002;18:361422.CrossRefGoogle Scholar
4.Lampe, K, Makela, M, Velasco Garrido, M, et al.The HTA core model: A novel method for producing and reporting health technology assessments. Int J Technol Assess Health Care. 2009;25 (Suppl 2):920.CrossRefGoogle Scholar
5.Catalan Agency for Health Technology Assessment and Research. EUnetHTA Work Package 8. EUnetHTA Handbook on Health Technology Assessment Capacity Building. Catalan Health Service. Barcelona: Department of Health Autonomous Government of Catalonia; 2008.Google Scholar
6.Murphy, K, Packer, C, Stevens, A, et al.Effective early warning systems for new and emerging health technologies: Developing an evaluation framework and an assessment of current systems. Int J Technol Assess Health Care. 2007;23:324330.CrossRefGoogle Scholar
7.Hailey, D. Toward transparency in health technology assessment. A checklist for HTA reports. Int J Technol Assess Health Care. 2003;19:17.CrossRefGoogle ScholarPubMed
8.Drummond, M, Schwartz, J, Jonsson, B, et al.Key principles for the improved conduct of health technology assessments for resource allocation decisions. Int J Technol Assess Health Care. 2008;24:244258.CrossRefGoogle ScholarPubMed
9.World Bank. Definition of the World Bank for lower-middle-income countries. http://data.worldbank.org/about/country-classifications/country-and-lending-groups (accessed on March 1, 2012).Google Scholar
10.Oortwijn, W, Mathijssen, J, Banta, D. The role of health technology assessment on pharmaceutical reimbursement in selected middle-income countries. Health Policy. 2010;95:174184.CrossRefGoogle ScholarPubMed
11.Organisation for Economic Cooperation and Development (OECD). The OECD Health Project. Health Technologies and Decision Making. Paris: OECD; 2005.Google Scholar